106 related articles for article (PubMed ID: 11781107)
1. Solution structure of human apolipoprotein(a) kringle IV type 6.
Maderegger B; Bermel W; Hrzenjak A; Kostner GM; Sterk H
Biochemistry; 2002 Jan; 41(2):660-8. PubMed ID: 11781107
[TBL] [Abstract][Full Text] [Related]
2. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
[TBL] [Abstract][Full Text] [Related]
3. High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand binding.
Ye Q; Rahman MN; Koschinsky ML; Jia Z
Protein Sci; 2001 Jun; 10(6):1124-9. PubMed ID: 11369850
[TBL] [Abstract][Full Text] [Related]
4. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
5. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
6. Kringle solution structures via NMR: two-dimensional 1H-NMR analysis of horse plasminogen kringle 4.
Cox M; Schaller J; Boelens R; Kaptein R; Rickli E; Llinás M
Chem Phys Lipids; 1994 Jan; 67-68():43-58. PubMed ID: 8187244
[TBL] [Abstract][Full Text] [Related]
7. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10.
Rahman MN; Becker L; Petrounevitch V; Hill BC; Jia Z; Koschinsky ML
Biochemistry; 2002 Jan; 41(4):1149-55. PubMed ID: 11802713
[TBL] [Abstract][Full Text] [Related]
8. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.
Klezovitch O; Scanu AM
Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):392-8. PubMed ID: 8630665
[TBL] [Abstract][Full Text] [Related]
9. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
10. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
Edelstein C; Mandala M; Pfaffinger D; Scanu AM
Biochemistry; 1995 Dec; 34(50):16483-92. PubMed ID: 8845377
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
Klezovitch O; Edelstein C; Scanu AM
J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.
Byeon IJ; Llinás M
J Mol Biol; 1991 Dec; 222(4):1035-51. PubMed ID: 1762144
[TBL] [Abstract][Full Text] [Related]
14. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
15. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
Hermann A; Laws WR; Harpel PC
Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
[TBL] [Abstract][Full Text] [Related]
16. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.
Christen MT; Frank P; Schaller J; Llinás M
Biochemistry; 2010 Aug; 49(33):7131-50. PubMed ID: 20617841
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1.
Rejante MR; Llinás M
Eur J Biochem; 1994 May; 221(3):939-49. PubMed ID: 8181476
[TBL] [Abstract][Full Text] [Related]
18. Effects of wild-type (Trp72) and mutant (Arg72) apolipoprotein(a) kringle IV-10 on the proliferation of human arterial smooth muscle cells.
Yu H; Hong J; Wang B; Peng F; Li X; He C
Chin Med J (Engl); 2003 May; 116(5):721-6. PubMed ID: 12875689
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
20. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
